drugset / Trial / NCT04535427
Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis
RandomizedParallel-groupSingle-blindTreatment
Summary
To investigate the role of L-arginine supplementation in the treatment of DMARDs-refractory moderate to severe rheumatoid arthritis
Timeline
- Start
- 2021-01-01
- Primary completion
- 2023-01-01
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-arginine | Small molecule | 3 g | — |
| Subject | L-arginine | Small molecule | 5 g | — |